Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer. (April 2021) - Spring, L.M.; Han, H.; Hamilton, E.; Irie, H.; Santa-Maria, C.A.; Reeves, J.; Pan, P.; Shan, M.; Tang, Y.; Graham, J.R.; Hazard, S.; Ellisen, L.W.; et al.